What are the benefits and risks of administering oral nutrition versus intravenous fluids in pediatric patients under 24 months receiving HFNC therapy for bronchiolitis?
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Both enteral and intravenous hydration for infants on HFNC therapy in bronchiolitis have benefits and risks. Enteral hydration shows low complication rates and potential improvements in clinical parameters, while IV fluids maintain electrolyte balance but pose practical challenges.
Fields of Study & Subjects
Clinical Nutrition and Gastroenterology
Respiratory viral infections research
Respiratory Support and Mechanisms
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 13 February 2026
- Language
- EN